agena-bioscience-logo
  • Products
  • Applications
  • Customer Success
  • Company
  • Contact
EN - Global CN - 中国 JP - 日本

menu

agena-bioscience-logo agena-bioscience-logo Close
  • Home
  • Products
    • System
    • Panels
  • Applications
  • Customer Success
  • Services
    • Assays by Agena
    • Certified Service Providers
    • MassARRAY Insights
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Management & Board
    • Careers
    • Press
    • Seminars & Webinars
  • Contact
  • Customer Support Portal
  • Home
  • Products
    • System
    • Panels
  • Applications
  • Customer Success
  • Services
    • Assays by Agena
    • MassARRAY Insights
    • Certified Service Providers
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Management & Board
    • Careers
    • Press
    • Seminars & Webinars
  • Contact
  • Customer Support Portal

Phone: (858) 882-2800

Home / Resources / Publication Library

Search Results for: Liquid Biopsy

Search All publications

How recent?
  • EGFR T790M mutation testing within the osimertinib AURA Phase I study
  • Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
  • Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
  • ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis
  • A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection
  • Circulating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types
  • Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
  • Response: Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance …
  • Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
  • Impact of blood collection tubes on CTC-, ctDNA-and miRNA recoveries in malignant melanoma patients
«12345...»
Company
  • Seminars & Webinars
  • About Us
  • Contact
  • Careers
Customer Support
  • Customer Support Portal
  • Support Contacts
  • English - Global
  • China - 中国
  • Japan - 日本
Agena Bioscience

4755 Eastgate Mall,
San Diego, CA 92121

p. (858) 882-2800,  f. (858) 882-2727

With exception of the MassARRAY Dx and MassARRAY SARS-CoV-2 Panel, all other products are For Research Use Only.
Not for use in diagnostic procedures. © 2021 Agena Bioscience, Inc. All rights reserved.

  • Privacy Policy
  • Website Terms & Conditions
  • Product Terms & Conditions
  • Warranty